Rossford, OH, United States of America

Erin Crawford



 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Erin Crawford

Introduction

Erin Crawford is a notable inventor based in Rossford, Ohio, who has made significant contributions to the field of nucleic acid sequencing. With a total of 11 patents to her name, she is recognized for her innovative methods that enhance the efficiency and accuracy of genetic testing.

Latest Patents

Crawford's recent patents focus on cutting-edge techniques for the standardized sequencing of nucleic acids. One of her notable patents describes methods for controlling non-systematic errors in amplification-based next-generation sequencing (NGS) library preparation. This method involves the use of an internal amplification control (IAC) that shares identical priming sites to the native nucleic acid target template of interest. Furthermore, her innovations aim to streamline the identification of genetic information, making it more accessible and affordable for the diagnosis and treatment of various diseases.

Career Highlights

Throughout her career, Erin Crawford has collaborated with esteemed institutions, including the University of Toledo, where she has advanced her research endeavors. Additionally, she has worked with Gene Express, Inc., where her innovative mindset has contributed to numerous breakthroughs in the biotech industry.

Collaborations

Crawford has had the opportunity to collaborate with notable colleagues, including James C. Willey and Thomas M. Blomquist. Their collective expertise in the field has further propelled the development of innovative solutions within genetic sequencing and diagnostics.

Conclusion

Erin Crawford is an influential figure in the realms of biotechnology and genetic research. Her inventive contributions and collaborative efforts continue to shape the future of nucleic acid sequencing, highlighting her commitment to improving healthcare outcomes through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…